New Vernon Capital Holdings Ii LLC Moderna, Inc. Transaction History

New Vernon Capital Holdings Ii LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $16,473 - $24,749	-237 Reduced 8.29%	2,623 $260,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $40,781 - $53,556	423 Added 17.36%	2,860 $295,000
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $97,170 - $131,634	820 Added 50.71%	2,437 $296,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $1,492 - $2,167	11 Added 0.68%	1,617 $248,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $26,753 - $47,469	226 Added 16.38%	1,606 $288,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $132,002 - $217,093	-1,118 Reduced 44.76%	1,380 $163,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $292,590 - $441,121	2,498 New	2,498 $357,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.